In this study, we explored the mechanism of chemoresistance from the perspective of chemotherapy-induced ER stress, screened out EDEM1 as a crucial regulator of DOX-induced ER stress, verified its role in promoting breast cancer progression and DOX resistance, and proved its prognostic value in breast cancer (Fig. 8). Here, EDEM1 is linked to breast carcinoma.